[HTML][HTML] Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
Q Li, W Wong, A Birnberg, A Chakrabarti, X Yang… - BMC Pulmonary …, 2021 - Springer
Background Chronic obstructive pulmonary disease (COPD) exacerbations are
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
[HTML][HTML] Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
Q Li, W Wong, A Birnberg… - BMC …, 2021 - bmcpulmmed.biomedcentral.com
Chronic obstructive pulmonary disease (COPD) exacerbations are heterogenous and
profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic acid (LPA) has …
profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic acid (LPA) has …
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
Q Li, W Wong, A Birnberg, A Chakrabarti… - BMC Pulmonary …, 2021 - search.proquest.com
Background Chronic obstructive pulmonary disease (COPD) exacerbations are
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease.
Q Li, W Wong, A Birnberg, A Chakrabarti… - BMC Pulmonary …, 2021 - europepmc.org
Background Chronic obstructive pulmonary disease (COPD) exacerbations are
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
[HTML][HTML] Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
Q Li, W Wong, A Birnberg, A Chakrabarti… - BMC Pulmonary …, 2021 - ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) exacerbations are
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
Q Li, W Wong, A Birnberg… - BMC pulmonary …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) exacerbations are
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease.
Q Li, W Wong, A Birnberg, A Chakrabarti… - BMC Pulmonary …, 2021 - go.gale.com
Background Chronic obstructive pulmonary disease (COPD) exacerbations are
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease.
Q Li, W Wong, A Birnberg… - BMC Pulmonary …, 2021 - search.ebscohost.com
Abstract < bold> Background: </bold> Chronic obstructive pulmonary disease
(COPD) exacerbations are heterogenous and profoundly impact the disease trajectory …
(COPD) exacerbations are heterogenous and profoundly impact the disease trajectory …
[PDF][PDF] Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
Q Li, W Wong, A Birnberg, A Chakrabarti, X Yang… - 2021 - bmcpulmmed.biomedcentral.com
Background: Chronic obstructive pulmonary disease (COPD) exacerbations are
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …